Integra LifeSciences Holdings Corporation (IART) Profit Margins
Over the twelve months to 2026-09-30, Integra LifeSciences Holdings Corporation (IART) had gross margin 52.4%, operating margin 4.4%, net margin 0.8%, free cash flow margin 5.2%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-09-30 · read by EquiReason
IARTIntegra LifeSciences Holdings CorporationFollow IART — free
—
Price chart with a free account
- Market cap
- 926.6M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 24 Feb, in 123 days
| Line | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Sep 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 61.2% | 62.8% | 62.0% | 61.2% | 62.3% | 57.4% | 54.8% | 50.9% | 52.4% | |
| Operating margin | 7.5% | 6.2% | 11.0% | 12.8% | 15.3% | 7.2% | 1.8% | -30.2% | 4.4% | |
| Net margin | 4.1% | 3.3% | 9.8% | 11.0% | 11.6% | 4.4% | -0.4% | -31.6% | 0.8% | |
| FCF margin | 8.3% | 10.7% | 12.0% | 17.1% | 14.3% | 4.7% | 1.6% | -1.9% | 5.2% |
USD billions · SEC XBRL
Integra LifeSciences Holdings Corporation — questions
- What is Integra LifeSciences Holdings Corporation's gross margin?
- 52.4% over the twelve months to 2026-09-30.
- What is Integra LifeSciences Holdings Corporation's operating margin?
- 4.4% over the twelve months to 2026-09-30.
- What is Integra LifeSciences Holdings Corporation's net profit margin?
- 0.8% over the twelve months to 2026-09-30.
Every figure on this page comes from Integra LifeSciences Holdings Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.